MONTREAL -- (MARKET WIRE) -- February 07, 2007 -- ART Advanced Research Technologies Inc. ("ART")(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that it has received the CE certificate which entitles it to affix the CE marking on its SoftScan® optical breast imaging device, making the device approved for sale throughout the European market.
